Aller au contenu principal
Profil bibliographique

Petroula Arapantoni-Dadioti

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

39Publications signalées
493Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchHead and Neck Cancer StudiesBreast Lesions and CarcinomasGlioma Diagnosis and Treatment

Les publications récentes

Accès ouvert 2025 article OpenAlex

Integrating molecular classification in adenoid cystic carcinoma of the head and neck: The experience from four tertiary centers in Greece

Panagiota Economopoulou, Theodoros Pantazopoulos, Danai Leventakou, Nektarios I. Koufopoulos et autres

BACKGROUND: Recently, a molecular characterization of adenoid cystic carcinoma (ACC) has been proposed, based on upregulation of c-Myc, a proto-oncogene involved in carcinogenesis, and p63, a transcription factor of the p53 gene family. The aim of this study was to evaluate c-Myc …

gr (code pays fourni par la source)

0 citations Oral Oncology
Accès ouvert 2025 article OpenAlex

61P Deep learning prediction of response to antibody-drug conjugates in patients with metastatic breast cancer using digital pathology

Suresh Jayabalan, Niki Arnogiannaki, Kyriaki Papadopoulou, Electra Sofou et autres

Antibody-drug conjugates (ADCs) have altered the therapeutic landscape of advanced breast cancer (aBC). We developed a prognostic deep learning-based model on whole-slide images (WSIs) from patients (pts) with aBC treated with ADCs.

de, gr (code pays fourni par la source)

0 citations ESMO Open
Accès ouvert 2024 article OpenAlex

Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns

Elena Fountzilas, Theofanis Papadopoulos, Eirini Papadopoulou, Cédric Gouédard et autres

Determination of microsatellite instability (MSI)/mismatch repair (MMR) status in cancer has several clinical implications. Our aim was to integrate MSI/MMR status from patients tested in Greece to assess the prevalence of MSI-high (MSI-H)/deficient MMR (dMMR) per tumor type, testing patterns over time …

cy, gr (code pays fourni par la source)

7 citations Diagnostics
Accès ouvert 2023 article OpenAlex

Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes

Foteinos-Ioannis D. Dimitrakopoulos, ANNA C. GOUSSIA, Georgia-Angeliki Koliou, Katerina Dadouli et autres

Background Dose-dense sequential (dds) chemotherapy has changed the clinical outcome of patients with early breast cancer (BC). To investigate the impact of dose intensity (DI) in the adjuvant setting of BC, this observational trial (HE 10/10) was conducted assessing the long-term survival …

gr, cy (code pays fourni par la source)

10 citations The Breast
Accès ouvert 2023 article OpenAlex

79P Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: An observational study with concurrent investigation of significance of TILs

F-I.D. Dimitrakopoulos, ANNA C. GOUSSIA, Georgia-Angeliki Koliou, Katerina Dadouli et autres

Dose-dense sequential (dds) chemotherapy has tremendously changed the clinical outcome of patients with early breast cancer (BC). To investigate the impact of dose intensity (DI) in the adjuvant setting of BC, this observational trial (HE 10/10) was conducted assessing the long-term survival …

gr, cy (code pays fourni par la source)

0 citations ESMO Open
2023 article OpenAlex

Significance of MYB and NTRK Expression in Head and Neck Adenoid Cystic Carcinoma

Theodoros Pantazopoulos, Danai Leventakou, Nektarios I. Koufopoulos, Abraham Pouliakis et autres

BACKGROUND/AIM: Adenoid cystic carcinoma (ACC) is an aggressive neoplasm even though it has low-grade histological appearance and slow growth. The aim of this study was to identify the immunohistochemical and molecular characteristics of ACC, as well as their correlation with the clinical …

gr (code pays fourni par la source)

4 citations Anticancer Research
Accès ouvert 2019 article OpenAlex

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab

Panagiota Economopoulou, Vassiliki Kotoula, Georgia-Angeliki Koliou, Kyriaki Papadopoulou et autres

BACKGROUND: Src, CDKN1B, and JAK2 play a crucial role in the coordination of cell signaling pathways. In the present study, we aim to investigate the prognostic significance of these biomarkers in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab (T). METHODS: …

gr (code pays fourni par la source)

6 citations Translational Oncology
2019 conference-abstract OpenAlex

Abstract P4-08-13: Prognostic significance of CD8+ tumor-infiltrating lymphocytes (TILs) in patients with early breast cancer (EBC) treated with dose-dense sequential adjuvant chemotherapy (dds-CT). An observational study (ACTRN12616001043426)

HP Kourea, Triantafyllia Κoletsa, Vassiliki Kotoula, G-A. Koliou et autres

Abstract Background - aim: Information on the prognostic role of cytotoxic CD8+ T cells in the era of modern adjuvant CT is limited. The primary objective of the present report is to assess the prognostic impact of CD8+ cells in patients with …

gr (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2017 article OpenAlex

Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group

Amanda K. Psyrri, Konstantine T. Kalogeras, Ralph Markus Wirtz, George Kouvatseas et autres

BACKGROUND: The shift towards an earlier diagnosis of breast cancer (BC) highlights the need for biomarkers that would identify patients at risk for relapse and metastatic spread and indicate the potential value of additional treatment strategies. Osteopontin (OPN) is a matricellular protein …

gr (code pays fourni par la source)

22 citations Journal of Translational Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.